Pharmaceuticals

SEELOS THERAPEUTICS INC

Seelos Therapeutics Inc. released FY2023 cumulative Q3 earnings on August 14, 2024 (EST), with actual revenue of 1.55M USD and EPS of -1.761K

Seelos Therapeutics Inc. released FY2024 H1 earnings on August 14, 2024 (EST) with actual revenue of 955K USD and EPS of -7.3872

Seelos Therapeutics Inc. released FY2023 H1 earnings on August 14, 2024 (EST), with actual revenue of 1.144 M USD and EPS of -1.348 K USD

Seelos Therapeutics Inc. released FY2023 Q1 earnings on May 14, 2024 (EST), with actual revenue of 808 K USD and EPS of -458.2707

Seelos Therapeutics Inc. released FY2024 Q1 earnings on May 14, 2024 (EST), with actual revenue of 579 K USD and EPS of -26.2147

Seelos Therapeutics Inc. released FY2023 annual earnings on March 6, 2024 (EST), with actual revenue of 2.203 M USD and EPS of -989.5253

Seelos Therapeutics Inc. released FY2022 earnings on March 6, 2024 (EST), with actual revenue of 0 USD and EPS of -2654.72

Rich Sparkle

Novabay Pharmac

Valens Semiconductor

Greenpower Motor

Alpha Tech

Offerpad Solutions

VCI Global

Tryhard

Tradr 2X Long APLD Daily ETF

ZeZentalis Pharma

Eli Lilly

Roche

ROCHE HOLDINGS AG

Astrazeneca

NOVARTIS AG

Novo Nordisk AS

Chugai Pharmaceutical

UCB S.A.

Daiichi Sankyo

Otsuka Pharmaceutical

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

SEELOS THERAPEUTICS INC(SEELQ.US)